Skip to content

Effect of Low Intensity Exercise and Protein Intake on Skeletal Muscle Protein Synthesis in Elderly

Impact of Acute Low Intensity Exercise and Protein Intake on Skeletal Muscle Protein Synthesis in Elderly: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01640145
Enrollment
30
Registered
2012-07-13
Start date
2012-07-31
Completion date
2014-10-31
Last updated
2015-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Protein Kinetics, Sarcopenia, Skeletal Muscle Protein Synthesis in Elderly

Brief summary

Maintenance of skeletal muscle mass is crucial during lifespan to retain health and functional autonomy. Sarcopenia, being the loss of muscle mass during aging, is a well-known phenomenon in the elderly and a major challenge viewed from an individual, and a socioeconomic point of view. Nevertheless, several studies have proved muscle tissue to be markedly affected by physical activity and nutritional interventions even at old age. Recently, a study in young individuals showed that an acute bout of easily tolerated low intensity exercise can prolong the muscle building effects of a milk protein intake compared to a non-exercised situation. Therefore, the major aim of the present project is to evaluate, whether a low intensity exercise regime in conjunction with milk protein supplementation can induce positive adaptations on parameters related to muscle size and function in elderly. The study focuses on the acute muscle protein synthesis response to low intensity exercise and protein supplementation measured with stable isotope tracer techniques. It is hypothesized that light muscle activity can augment and prolong the effects of protein feeding. If a light resistance exercise protocol as investigated in the present project can prove beneficial, elderly, frail elderly, and individuals undergoing rehabilitation can challenge sarcopenia in a new and tolerable way.

Interventions

DIETARY_SUPPLEMENTProtein

Whey protein intake

OTHERExercise

Unilateral low intensity exercise

Sponsors

Bispebjerg Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
MALE
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Male * \>65 year old * Healthy * BMI \<28

Exclusion criteria

* Smoker * Type II diabetic * Intake of medicine or supplements which will affect skeletal muscle protein synthesis * Alcohol intake \>21 units/week. * Frequent exercise or hard physical labor

Design outcomes

Primary

MeasureTime frameDescription
Skeletal muscle protein synthesis6 monthsMeasured as myofibrillar fractional synthetic rate (%/hour) in three periods pre intervention: 0-3 hours, 3-7 hours and 7-10 hours

Secondary

MeasureTime frameDescription
Gene expression1.5 yearsThrough real time RT-PCR we measure the fold changes in gene expression of targets involved in skeletal muscle remodeling: myogenic factors, atrogenes, matrix related genes
Intracellular signaling1.5 yearsThrough Western Blotting we will measure changes in intracellular hypertrophy signaling. That is the activity of protein targets from the Akt-mTORC1 and Akt-FOXO pathways.
Amino acid transporter2 yearsThrough Western Blotting and RT-PCR protein and mRNA expression of amino acid transporters (LAT1, SNAT2, PAT1) are analyzed

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026